The Role of Interventional Treatment for The Failing Grafts

Slides:



Advertisements
Similar presentations
Single Center Experience with Drug Eluting Stents for Infrapopliteal Occlusive Disease in Patients with Critical Limb Ischemia: Mid-term follow up Robert.
Advertisements

Management of distal peripheral vascular disease Cheuk Kwan Yee, Queenie Tuen Mun Hospital.
The Cramping Leg Management of peripheral vascular disease
For the motion: Endovascular Therapy is a better option for limb salvage in diabetic ulcer treatment Dr. Prasad Jetty Division of Vascular and Endovascular.
PERIPHERAL VASCULAR DISEASE: A VASCULAR SURGEON’S POINT OF VIEW
Viabahn Covered Stents for Cephalic Arch Stenosis Can Improve Patency and Longevity of Upper Arm AV Fistulas Toufic Safa, MD, FACS Vascular & Endovascular.
Superficial Femoral Artery Stents - Bare, Covered, or Drug-Coated – “The Data and The HYPE” Dennis F. Bandyk, MD Division of Vascular & Endovascular Surgery.
Evaluation of ReeKross balloon catheter in treating iliofemoral artery chronic total occlusions Xinwu Lu Vascular Center of Shanghai Jiaotong University.
Aims To evaluate the technical and clinical outcome of percutaneous transluminal infra-popliteal angioplasties (PTIA) +/- stenting in a subgroup of patients.
Post-Surgical Care for the Individual With PAD: A Shared Responsibility to Sustain Life and Limb.
Achieving Acute Success and Durable Results with Complete Total Occlusion? Christopher J. Kwolek, MD FACS Harvard Medical School Division of Vascular and.
Hemodialysis access: guidelines, evidence and controversies Marc R Lilien, MD, PhD Pediatric nephrologist.
SIROLIMUS-ELUTING STENTS EFFECTIVELY INHIBIT NEOINTIMAL PROLIFERATION AS COMPARED TO BARE METAL STENTS IN DISEASED SAPHENOUS VEIN GRAFTS: 6-month IVUS.
Endovascular treatment on tandem lesions of cranial arteries Xiao-Long Zhang, MD, PhD Department of Radiology Huashan Hospital,Fudan University Shanghai.
Faisal Alam Consultant Vascular & General Surgeon Royal Hospital.
Peripheral Vascular Disease
The most important principle in treating foot ischemia in patients with diabetes is recognition that the etiology of this ischemia is macrovascular.
TOKUDA HOSPITAL SOFIA VASCULAR SURGERY AND ANGIOLOGY DEPARTMENT DR. A. DASKALOV, ASSOC. PROFF. V. CHERVENKOV.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Nitinol Stents with Polymer-free Paclitaxel Coating
The angiosome concept; open and endovascular treatment of CLI
Chapter 13 Evaluation of arterial bypass grafts and stents
Subclavian, Innominate & Vertebral Artery Treatment
Intervention for Chronic Lower Extremity Venous Obstruction
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
Heavily calcified SFA lesions do not avoid the use of 4 F systems
Treatment of iliac vein obstruction
Stent Graft for the Treatment of ISR:
Damian Gimpel Waikato Cardiothoracic Unit Journal Club
(A) This is an ex vivo angiogram of a harvested left greater saphenous vein. We have begun using an ex vivo angiogram of the harvested vein graft for examination.
Treatment of iliac vein obstruction
Acute Arterial Clot Management
The Winking Saphenous Vein Graft: Acute Aorto-Vein Graft Anastomotic Torsional Kink causing Dynamic Systolic Compression Complicating Vein Graft PCI Dr.
Excimer Laser Atherectomy for the Treatment of Infra-inguinal Peripheral Arterial Disease Bryan P Yan MD, Thomas J Kiernan MD, Vishal Gupta MD,
Debate: The Femoral Artery - Common Femoral & Popliteal Artery Stenosis: “No Stent Zones” Are Best Managed Surgically Rabih A. Chaer MD Assistant Professor.
Instent Restenosis and Occlusion: Time for Surgical Revision?
Recanilization of Central Venous Total Occlusions
Percutaneous Reconstruction of the Aortoiliac Bifurcation
ALAA GABI, MD SUPERVISOR: MEHIAR EL-HAMDANI, MD
Post-Surgical Care for the Individual With PAD
Adam W. Beck, MD, Erin H. Murphy, MD, Jennie A
Giuseppe Biondi Zoccai
Long-term follow-up of the DIABETES I (DIABETes and sirolimus Eluting Stent) trial: P Jiménez-Quevedo, M Sabaté, DJ Angiolillo, JA Gómez-Hospital, R Hernández-Antolín,
Section 5: Intervention and drug therapy
Results ASA score: Epidemiological data: 8 patients: 7 men and 1 woman
FAIR Trial design: Patients with SFA in-stent restenosis (ISR) were randomized to either a paclitaxel-coated balloon (DCB) (dose 3.5 μg/mm2) or routine.
VASCULAR SURGERY STATIONS
RAPID and VISION September 10, 2018 VISION Think Tank Meeting
Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease  Hasan H. Dosluoglu, MD, Purandath Lall,
Christopher D. Owens, MD, MSc  Journal of Vascular Surgery 
Challenges of distal bypass surgery in patients with diabetes: Patient selection, techniques, and outcomes  Michael S. Conte, MD  Journal of Vascular.
Open surgical and endovascular treatment of superior vena cava syndrome caused by nonmalignant disease  Manju Kalra, MBBS, Peter Gloviczki, MD, James.
Surgical or endovascular revascularization in patients with critical limb ischemia: Influence of diabetes mellitus on clinical outcome  Florian Dick,
Christopher D. Owens, MD, MSc  Journal of Vascular Surgery 
Percutaneous revascularization strategies in a patient with previous coronary artery bypass surgery: Technical and patho-physiological insights  Pierfrancesco.
Reconstruction of the superior vena cava: Benefits of postoperative surveillance and secondary endovascular interventions  Yves S. Alimi, MD, Peter Gloviczki,
Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease  Jean-Baptiste Ricco,
Walter J. McCarthy, MD, William H. Pearce, MD, William R
Clinical efficacy of concomitant tibial interventions associated with superficial femoral artery interventions in critical limb ischemia  Christopher.
Endovascular aortoiliac grafts in combination with standard infrainguinal arterial bypasses in the management of limb-threatening ischemia: Preliminary.
Division of Endovascular Interventions
Do normal early color-flow duplex surveillance examination results of infrainguinal vein grafts preclude the need for late graft revision?  Marc A. Passman,
Endovascular treatment of atherosclerotic popliteal artery disease based on dynamic angiography findings  Chaoyi Cui, MD, PhD, Xintian Huang, MD, Xiaobing.
Suggested objective performance goals and clinical trial design for evaluating catheter- based treatment of critical limb ischemia  Michael S. Conte, MD,
A personal experience with the influence of diabetes and other factors on the outcome of infrainguinal bypass grafts for occlusive disease  Norman R.
Balloon angioplasty for revision of failing lower extremity bypass grafts  Haitham Ali, MD, Ahmed Elbadawy, MD, Mahmoud Saleh, MD, Ayman Hasaballah, MD 
Vascular Surgery Michael Ricci, MD.
Surgical and endovascular revision of infrainguinal vein bypass grafts: Analysis of midterm outcomes from the PREVENT III trial  Scott A. Berceli, MD,
James E. Edwards, MD, Lloyd M. Taylor, MD, John M. Porter, MD 
Limb salvage after infrainguinal bypass graft failure
Presentation transcript:

The Role of Interventional Treatment for The Failing Grafts Marin POSTU IECVD “C.C.Iliescu” Bucharest, ROMANIA

Patient with the most severe manifestations of lower extremity arterial occlusive disease often require peripheral bypass surgery for limb salvage and preservation of function 5 years failure rate (in good quality conditions) are 30-50% - unchanged for the past two decades The majority occur within the first year

The failing graft – the graft that has one or multiple hemodinamically significant stenosis that, if unrepaired, may lead to a failure. There are three distinct temporal phases of failure - early – within 30 days - mid-term – 3-24 months - late - > 2 years 5-10 % generally ascribed to technical complication ascribed to the development of intimal hyperplasia and progression of atherosclerotic degeneration in the native arterial tree

Anatomical classification of failing grafts  Lesion on native vessel    Lesion on anastomosis        Lesion on grafts          - Run in vessel - Run off vessel - Proximal anastomosis - Distal anastomosis

Reporting standards have recommended defining bypass graft endpoints into three categories Primary patency – uninterrupted patency with no procedure or intervention Primary assisted patency – is never lost but is maintained by prophylactic intervention endovascular or surgical Secondary patency – the time from implantation until the graft is occluded

The pooled weighted data for 1,3 and 5 years primary patency for femuro-distal bypass Venous bypass Prosthetic bypass 1 year 85% 3 years 80% 5 years 70% 1 year 70% 3 years 35% 5 years 25% * ESC guidelines

Recommendations for surgical revascularization in patient with lower extremity artery disease Class of recommendation I Level of evidence A When surgery is considered to revascularize infrailiac lesions, the autogenous saphenous vein is the bypass graft of choice * ESC guidelines

SURVEILLANCE There is no consensual protocol, but regular monitoring of revascularized limbs can permit a prompt prophylactic interventions and improve long term patency * Multicenter randomized trial included 594 pts. with vein graft found that a systematic duplex surveillance was not found to be beneficial in terms of short patency and limb survival rate and was less cost effective that clinical surveillance *. * ESC guidelines * Davies AV et al. study Circulation 2005

SURVEILLANCE ACC AHA Guidelines Recommendation Class. I, level of evidence B Long-term patency of infrainghinal bypass grafts should be evaluated in a surveillance program, which should include an interval vascular history , physical examination and a duplex ultrasound at regular intervals if a venous conduit has been used. The detection of a flow-limiting lesion has significant implication that permit improved maintenance of the long term patency of the instrumented native vessel or graft. As a result follow-up of autogenous vein bypass graft should be performed with duplex USG at intervals of 1,3,6,12,18 and 24 months and then annually.

Study Gregory A. Carlson et al. Iowa, USA, J.Vasc Surgery 2004 Retrospective study to evaluate the role of balloon angioplasty in the treatment of failing infrainguinal vein bypass grafts 1990-2001 Initial success 91.7% Cumulative primary patency Cumulative assisted patency CONCLUSION: This procedure should be considered as an initial option in failing infrainguinal vein bypass grafts - 74.2% at 6 months - 62.6% at 12 months - 58.2% at 24 months - 87.0% at 6 months 83.2% at 12 months 78.9% at 24 months

Angioplasty for Diabetic Patients with Failing Bypass Graft or Residual critical Ischemia after Bypass Graft, E. Faglia et al.,Eur. J. Vasc. Endovascular Surgery (2008) 36 Successful PTA was in 78.1% Follow up – 1.89±0.27 years find 28% restenosis After repeated angioplasty Conclusions : PTA is an elective method for revascularizing secondary obstructions in patients with graft failure - the cumulative primary patency was 72% - the assisted patency 92%

Balloon Angioplasty at the Primary Treatment for Failing Infra-inguinal Vein Grafts, R.Mofidi et al., European Journal of Vascular Endovascular Surgery 2009/37 411 grafts were followed up for a median 19 months 22.6% developed critical stenosis 76 patients underwent endovascular procedure Technical success – 78.9% Repeat angioplasty – technical success 75% No difference was observed in graft patency (p=0.08) or amputation rate (p=0.32) between the grafts requiring intervention to maintain patency and grafts which did not Conclusions: Balloon angioplasty of failing infra-inguinal vein bypass grafts is safe and can be performed with an acceptable medium term patency rate

Male, 62 years old smoking, diabetes, dyslipidemia critical ischemia of left lower extremity after 2 months from venous femuro-popliteal bypass

63 years old male hypertension, dyslipidemia femuro-popliteal venous bilateral bypass critical ischemia of left lower extremity after one year from bypass surgery

OTW balloon 4,0/100 mm

61 years old female smoking, dyslipidemia bilateral femuro-popliteal venous bypass critical ischemia of left lower extremity after 3 months from surgery

OTW balloon 6,0/120 mm

77 years old male hypertension, dyslipidemia, obesity left femuro-popliteal venous bypass critical ischemia after 8 months

after 2 years patient came back with critical ischemia of the left lower extremity

Conclusion Follow-up of bypass graft should be performed by clinical examination and if it possible with duplex USG for prevention of reoccurrence of symptoms Endovascular intervention should be considered as an initial option in failing infrainguinal vein bypass graft PTA is an elective method for revascularizing secondary obstructions in patients with graft failure

Discussion The high rate of restenosis after PTA may suggest that the use of pharmacologically active stents and balloons can increase primary patency after PTA

Failing Andie Brandt Describe your life in one word. Failure. I often find myself failing ………………………… But you see there's something I realized ………………………… ……with my survival There's something successful